Skip to main content
Earnings Labs
Dianthus Therapeutics, Inc. logo

Dianthus Therapeutics, Inc. (DNTH)

NASDAQ·Healthcare·Biotechnology

$86.31

+0.33%

Mkt Cap $4.81B

Analyst Ratings

Buy

5

Hold

0

Sell

0

Price Target (23 analysts)

$126.83

Range $98.00 – $158.00

Implied Upside

+46.9%

Consensus $126.83 vs current $86.31